ESMO Gastrointestinal Oncology

Novel blood signature for HCC screening

Pub Date : 2025-06-18 DOI: 10.1016/j.esmogo.2025.100185 K.-M. Chueng , K.-N. Kwok , S.J.-L. Lam , H.-S. Lam , S.-M. Yip , S. Lam , O.-P. Chiu , A.K.-Y. Chan , H.H.-W. Liu , S.K.-K. Ng , L. Sutanto , J.C.K. Yung , H.-L. Leung , P.Y.-M. Woo , H.H.-Y. Yiu , D.C.C. Lam

Managing adverse events in patients with metastatic colorectal cancer receiving trifluridine/tipiracil in combination with bevacizumab

Pub Date : 2025-06-16 DOI: 10.1016/j.esmogo.2025.100191 M. Fakih , F. Ciardiello , G.W. Prager , E. Élez , E. Calleja , N. Caussé-Amellal , J. Taieb , E. Van Cutsem

Genomic heterogeneity and clinical implications in gastrointestinal neuroendocrine carcinoma: MYC and KRAS as predictive biomarkers

Pub Date : 2025-06-11 DOI: 10.1016/j.esmogo.2025.100193 T. Ozato , Y. Kono , H. Yamamoto , A. Hirasawa , D. Ennishi , S. Tomida , S. Toyooka , M. Otsuka